[Early complications after intra-cervical application of prostaglandin F2 alpha gel for therapeutic abortion (author's transl)].
The intracervical application of prostaglandin F2 alpha gel reduced the hospital stay compared to previous methods of therapeutic abortion by one day. The operative technique of the therapeutic abortion is simplified by the medical dilatation of the cervix by the prostaglandin gel. The early complication rate was 10% initially but was reduced to 5% when the application time of prostaglandin gel was reduced from 18 to 14 hours and suction curettage introduced instead of sharp curettage. The side effect rate of the prostaglandin gel was relatively high with 14%. Many patients complained about severe labor like pain which responds poorly to analgesics. Therefore the application of intracervical prostaglandin gel is only recommended for therapeutic abortions beyond nine weeks gestation. Prior to nine weeks gestation suction curettage only is recommended.
D000028:Abortion, Induced; D000293:Adolescent; D000328:Adult; D002584:Cervix Uteri; D005260:Female; D006801:Humans; D011247:Pregnancy; D011460:Prostaglandins F / Q000008:administration & dosage / Q000009:adverse effects*
D011460:Prostaglandins F
Frühkomplikationen nach intrazervikaler Prostaglandin-F2-Alpha-Gel-applikation zur Abruptio graviditatis.